Ultra-high-scale cytometry-based cellular interaction mapping
- PMID: 40775086
- DOI: 10.1038/s41592-025-02744-w
Ultra-high-scale cytometry-based cellular interaction mapping
Abstract
Cellular interactions are of fundamental importance, orchestrating organismal development, tissue homeostasis and immunity. Recently, powerful methods that use single-cell genomic technologies to dissect physically interacting cells have been developed. However, these approaches are characterized by low cellular throughput, long processing times and high costs and are typically restricted to predefined cell types. Here we introduce Interact-omics, a cytometry-based framework to accurately map cellular landscapes and cellular interactions across all immune cell types at ultra-high resolution and scale. We demonstrate the utility of our approach to study kinetics, mode of action and personalized response prediction of immunotherapies, and organism-wide shifts in cellular composition and cellular interaction dynamics following infection in vivo. Our scalable framework can be applied a posteriori to existing cytometry datasets or incorporated into newly designed cytometry-based studies to map cellular interactions with a broad range of applications from fundamental biology to applied biomedicine.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare the following competing interests: S.H., S.Y., V. Flore, I.S.V., C.E., R.T., D.H., D.V., L.J.-S. and A.T. are listed as inventors for the European Patent Application no. 24181153.8 from the Charité – Universitätsmedizin Berlin and Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (priority application filed). The patent covers the core technology and applications of the Interact-omics framework. S.K. has received honoraria from Cymab, Plectonic, TCR2 Inc., Novartis, BMS, Miltenyi and GSK. S.K. is inventor of several patents in the field of immuno-oncology. S.K. received license fees from TCR2 Inc. and Carina Biotech. D.H. owns stock from Platomics GmbH. The other authors declare no competing interests.
Similar articles
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
High-throughput library transgenesis in Caenorhabditis elegans via Transgenic Arrays Resulting in Diversity of Integrated Sequences (TARDIS).Elife. 2023 Jul 4;12:RP84831. doi: 10.7554/eLife.84831. Elife. 2023. PMID: 37401921 Free PMC article.
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
-
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec. Autism Adulthood. 2024. PMID: 40018061 Review.
-
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.Cochrane Database Syst Rev. 2001;(3):CD003234. doi: 10.1002/14651858.CD003234. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234. doi: 10.1002/14651858.CD003234.pub2. PMID: 11687058 Updated.
References
-
- Armingol, E., Officer, A., Harismendy, O. & Lewis, N. E. Deciphering cell-cell interactions and communication from gene expression. Nat. Rev. Genet. 22, 71–88 (2021). - PubMed
-
- Cooper, G. M. in The Cell: A Molecular Approach (ed. Cooper, G. M.) 2nd edn, Ch. 12 (Sinauer Associates, 2000).
-
- Bechtel, T. J., Reyes-Robles, T., Fadeyi, O. O. & Oslund, R. C. Strategies for monitoring cell-cell interactions. Nat. Chem. Biol. 17, 641–652 (2021). - PubMed
LinkOut - more resources
Full Text Sources